Giorgio Sesti

Researcher Next ID · RN-034465

Researcher · Biochemistry, Genetics and Molecular Biology

Stockholm, Sweden

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Diabetes Treatment and Management

Diabetes, Cardiovascular Risks, and Lipoproteins

Metabolism, Diabetes, and Cancer

Pancreatic function and diabetes

Cardiovascular Function and Risk Factors

International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes
Diabetes Research and Clinical Practice · 2024 · https://doi.org/10.1016/j.diabres.2024.111589
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
The Lancet Diabetes & Endocrinology · 2017 · https://doi.org/10.1016/s2213-8587(17)30317-0
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)60659-0
Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells
Circulation · 2002 · https://doi.org/10.1161/01.cir.0000023043.02648.51
High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans
Diabetes · 2001 · https://doi.org/10.2337/diabetes.50.6.1290
Defects of the insulin receptor substrate (IRS) system in human metabolic disorders
The FASEB Journal · 2001 · https://doi.org/10.1096/fj.01-0009rev

No projects listed.